---
company: AMBARELLA INC
ticker: AMBA
form: 8-K
filed: 2026-09-03
accession: 0001193125-26-381923
source: https://www.sec.gov/Archives/edgar/data/1280263/000119312526381923/
---

# Ambarella (AMBA) earnings release, September 3, 2026

Ambarella Inc (AMBA) · Form 8-K, Item 2.02 · Filed 2026-09-03 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1280263/000119312526381923/)

Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results

September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended July 31, 2026.

Financial results on a non-GAAP basis for the second quarter of fiscal 2027 are as follows:

Based on information available as of today, Ambarella is offering the following guidance for the third quarter of fiscal year 2027, ending October 31,

2026:

Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis.

Non-GAAP financial information excludes the impact of stock-based compensation and acquisition-related costs adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. In addition, in our second quarter of fiscal 2027, we recognized a one-time

$9.0 million reduction in our GAAP research and development expense on release of a deposit liability following the termination of a development project. Given the nature of this credit and that it is non-recurring, we excluded it from operating expenses for the purpose of reporting non-GAAP financial results. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings

(losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end of the second quarter of fiscal 2027 was $272.3 million, compared with

$277.8 million at the end of the prior quarter and $261.2 million at the end of the same quarter a year ago.

“Our edge AI revenue reached record levels in Q2, with balanced sequential growth in Auto and IoT markets with very strong growth from our 5nm CV75 and CV72 AI SoCs. We are making significant progress with our strategic priorities to extend our market reach with new higher value products and the implementation of new go-to-market strategies. These include the introduction of our first stand-alone AI Accelerator, X7, and the execution of

7-year agreements to develop the indirect sales channel with both Macnica, a leading global technical distributor, and CapGemini, a leading global engineering and systems integration firm,” said Fermi Wang,

President & CEO. “These developments are contributing to an increase in our

5-year serviceable market (“SAM”) forecast for edge AI and Physical AI.”

Quarterly Conference Call

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the second quarter of fiscal year 2027 results. A live and archived webcast of the call will be available on Ambarella’s website at http://www.ambarella.com/ for up to 30 days after the call.

About

Ambarella

With an installed base of more than 50 million AI SoC units, Ambarella’s products are utilized in a wide variety of physical edge

AI applications, spanning edge endpoint and edge infrastructure use cases including physical security, vehicle safety, telematics, autonomy, portable video, aerial drones, and other emerging robotic applications. Building on this footprint,

Ambarella offers a full-stack edge AI platform, from highly optimized silicon and programmable software to AI agentic frameworks that coordinate perception, decision-making and control across devices. Ambarella’s low-power systems-on-chip

(SoCs) integrate proprietary and highly efficient perception and deep learning neural network AI accelerators, enabling electronic systems to become more productive with partial or complete levels of machine autonomy. For more information, please visit www.ambarella.com.

“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,”

“projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the guidance for the third quarter of fiscal year 2027 ending October 31, 2026, and the comments of our CEO relating to demand for edge AI solutions, our progress with strategic priorities to extend our market reach, our ability to successfully build an indirect sales channel, the forecasted size of our serviceable market (“SAM”), and our ability to successfully penetrate the edge AI and Physical AI markets. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies, including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as AI functionality and advanced networks, including vision-language models and GenAI; our ability to retain and expand customer relationships and to chieve design wins; the expansion of our current markets and our ability to successfully enter new markets and applications, such as edge infrastructure; anticipated trends and challenges, including competition, in the markets in which we operate; risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form

10-K for our 2026 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also be set forth in the company’s quarterly reports on Form

10-Q, annual reports on Form

10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Quarterly Report on Form

10-Q for the second quarter of fiscal 2027 ended July 31, 2026 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP

Financial Measures

The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income (loss), and earnings (losses) per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted accounting principles (“GAAP”). Management uses these non-GAAP financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods.

Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies.

Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP and may be different from non-GAAP measures used by other companies.

With respect to its financial results for the second quarter of fiscal year 2027, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the third quarter of fiscal year 2027, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

## Financial statements

### Income Statement (Three Months Ended July 31, — (unaudited) (in thousands))

| | Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | Six Months Ended July 31, – 2026 | Six Months Ended July 31, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 108,125 | 95,511 | 208,482 | 181,383 |
| Cost of revenue | 45,709 | 39,280 | 87,477 | 73,616 |
| Gross profit | 62,416 | 56,231 | 121,005 | 107,767 |
| Operating expenses: | Research and development | 50,581 | 59,734 | 108,721 | 118,553 |
| Operating expenses: | Selling, general and administrative | 19,978 | 18,486 | 39,843 | 37,061 |
| Operating expenses: | Total operating expenses | 70,559 | 78,220 | 148,564 | 155,614 |
| Operating expenses: | Loss from operations | -8,143 | -21,989 | -27,559 | -47,847 |
| Operating expenses: | Other income, net | 1,806 | 2,247 | 3,889 | 4,422 |
| Operating expenses: | Loss before income taxes | -6,337 | -19,742 | -23,670 | -43,425 |
| Operating expenses: | Provision for income taxes | 352 | 253 | 1,112 | 898 |
| Operating expenses: | Net loss | -6,689 | -19,995 | -24,782 | -44,323 |
| Net loss per share attributable to ordinary shareholders: | Basic | -0.15 | -0.47 | -0.57 | -1.05 |
| Net loss per share attributable to ordinary shareholders: | Diluted | -0.15 | -0.47 | -0.57 | -1.05 |
| Weighted-average shares used to compute net loss per share attributable to ordinary shareholders: | Basic | 44,005,576 | 42,546,979 | 43,805,429 | 42,383,475 |
| Weighted-average shares used to compute net loss per share attributable to ordinary shareholders: | Diluted | 44,005,576 | 42,546,979 | 43,805,429 | 42,383,475 |

### Income Statement (Three Months Ended July 31, (in thousands))

| | Three Months Ended July 31, – 2026 – (unaudited, in thousands) | Three Months Ended July 31, – 2025 – (unaudited, in thousands) | Six Months Ended July 31, – 2026 – (unaudited, in thousands) | Six Months Ended July 31, – 2025 – (unaudited, in thousands) |
|---|---:|---:|---:|---:|
| Stock-based compensation: | Cost of revenue | 951 | 780 | 1,734 | 1,731 |
| Stock-based compensation: | Research and development | 14,007 | 16,972 | 27,721 | 34,557 |
| Stock-based compensation: | Selling, general and administrative | 7,742 | 7,436 | 15,138 | 15,030 |
| Stock-based compensation: | Total stock-based compensation | 22,700 | 25,188 | 44,593 | 51,318 |
| Acquisition-related costs: | Cost of revenue | 757 | 757 | 1,514 | 1,514 |
| Acquisition-related costs: | Selling, general and administrative | 456 | 456 | 912 | 912 |
| Acquisition-related costs: | Total acquisition-related costs | 1,213 | 1,213 | 2,426 | 2,426 |
| Development project termination credit: | Cost of revenue |  |  | $— |  |
| Development project termination credit: | Research and development | -9,000 |  | -9,000 |  |
| Development project termination credit: | Total development project termination credit | -9,000 |  | -9,000 |  |

### Income Statement (Three Months Ended July 31, — (in thousands, except share and per share data))

| | Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 – (unaudited) | Six Months Ended July 31, – 2026 – (unaudited) | Six Months Ended July 31, – 2025 |
|---|---:|---:|---:|---:|
| GAAP net loss | -6,689 | -19,995 | -24,782 | -44,323 |
| Non-GAAP adjustments: | Stock-based compensation expense | 22,700 | 25,188 | 44,593 | 51,318 |
| Non-GAAP adjustments: | Acquisition-related costs | 1,213 | 1,213 | 2,426 | 2,426 |
| Non-GAAP adjustments: | Development project termination credit | -9,000 |  | -9,000 |  |
| Non-GAAP adjustments: | Income tax effect | 9 | 22 | 29 | 36 |
| Non-GAAP adjustments: | Non-GAAP net income | 8,233 | 6,428 | 13,266 | 9,457 |
| Non-GAAP adjustments: | GAAP - diluted weighted average shares | 44,005,576 | 42,546,979 | 43,805,429 | 42,383,475 |
| Non-GAAP adjustments: | Non-GAAP - diluted weighted average shares | 44,515,009 | 42,946,324 | 44,207,416 | 42,698,780 |
| Non-GAAP adjustments: | GAAP - diluted net loss per share | -0.15 | -0.47 | -0.57 | -1.05 |
| Non-GAAP adjustments: | Stock-based compensation expense | 0.52 | 0.59 | 1.02 | 1.21 |
| Non-GAAP adjustments: | Acquisition-related costs | 0.03 | 0.03 | 0.06 | 0.06 |
| Non-GAAP adjustments: | Development project termination credit | -0.2 |  | -0.21 |  |
| Non-GAAP adjustments: | Effect of Non-GAAP - diluted weighted average shares | -0.02 |  |  |  |
| Non-GAAP adjustments: | Non-GAAP - diluted net income per share | 0.18 | 0.15 | 0.3 | 0.22 |

### Balance Sheet ((unaudited, in thousands))

| | July 31, 2026 | January 31, 2026 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 101,850 | 191,019 |
| Current assets: | Marketable debt securities | 170,482 | 121,552 |
| Current assets: | Accounts receivable, net | 37,440 | 39,180 |
| Current assets: | Inventories | 76,923 | 52,246 |
| Current assets: | Restricted cash | 442 | 442 |
| Current assets: | Prepaid expenses and other current assets | 6,885 | 5,836 |
| Current assets: | Total current assets | 394,022 | 410,275 |
| Current assets: | Property and equipment, net | 12,061 | 11,553 |
| Current assets: | Intangible assets, net | 56,672 | 58,046 |
| Current assets: | Operating lease right-of-use assets, net | 10,923 | 12,118 |
| Current assets: | Goodwill | 303,625 | 303,625 |
| Current assets: | Other non-current assets | 2,902 | 2,983 |
| Current assets: | Total assets | 780,205 | 798,600 |
| Current liabilities: | Accounts payable | 26,478 | 54,029 |
| Current liabilities: | Accrued and other current liabilities | 86,490 | 97,964 |
| Current liabilities: | Operating lease liabilities, current | 2,229 | 2,027 |
| Current liabilities: | Income taxes payable | 2,309 | 1,531 |
| Current liabilities: | Deferred revenue, current | 20,865 | 22,393 |
| Current liabilities: | Total current liabilities | 138,371 | 177,944 |
| Current liabilities: | Operating lease liabilities, non-current | 10,413 | 11,408 |
| Current liabilities: | Other long-term liabilities | 11,105 | 14,459 |
| Current liabilities: | Total liabilities | 159,889 | 203,811 |
| Shareholders’ equity: | Ordinary shares | 20 | 19 |
| Shareholders’ equity: | Additional paid-in capital | 973,864 | 922,119 |
| Shareholders’ equity: | Accumulated other comprehensive income (loss) | -864 | 573 |
| Shareholders’ equity: | Accumulated deficit | -352,704 | -327,922 |
